UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

PloS one, 2010-08, Vol.5 (8), p.e12419-e12419

2010

Volltextzugriff (PDF)

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

The American journal of gastroenterology, 1999-09, Vol.94 (9), p.2467-2474

1999

Volltextzugriff (PDF)

Editorial: Feeling better about NASH

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (4), p.482-483

Di Bisceglie, Adrian M

2023

Volltextzugriff (PDF)

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.115-126

2017

Volltextzugriff (PDF)

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

PloS one, 2018-08, Vol.13 (8), p.e0196908-e0196908

2018

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Lipids in health and disease, 2020-11, Vol.19 (1), p.1-10, Article 239

2020

Volltextzugriff (PDF)

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1226-1236

2023

Volltextzugriff (PDF)

A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis

The American journal of gastroenterology, 2022-11, Vol.117 (11), p.1805-1815

2022

Volltextzugriff (PDF)

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

PloS one, 2014-07, Vol.9 (7), p.e101422-e101422

2014

Volltextzugriff (PDF)

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

PloS one, 2010-02, Vol.5 (2), p.e9032

2010

Volltextzugriff (PDF)

Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1214-1225

2023

Volltextzugriff (PDF)

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

Journal of general internal medicine : JGIM, 2020-04, Vol.35 (4), p.1011-1020

2020

Volltextzugriff (PDF)

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

PloS one, 2014-06, Vol.9 (6), p.e100131

2014

Volltextzugriff (PDF)

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

PloS one, 2013-06, Vol.8 (6), p.e64992-e64992

2013

Volltextzugriff (PDF)

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.1001-1011

2018

Volltextzugriff (PDF)

Prevention of Hepatocellular Carcinoma Resulting From Hepatitis B: Are We There Yet?

Clinical gastroenterology and hepatology, 2014-05, Vol.12 (5), p.894-896

Di Bisceglie, Adrian M., MD, FACP

2014

Volltextzugriff (PDF)

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus

Clinical gastroenterology and hepatology, 2010-03, Vol.8 (3), p.280-288.e1

2010

Volltextzugriff (PDF)

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status

The American journal of gastroenterology, 2003-09, Vol.98 (9), p.2060-2063

2003

Volltextzugriff (PDF)

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

Vaccine, 2010-08, Vol.28 (38), p.6367-6373

2010

Volltextzugriff (PDF)

Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

Clinical gastroenterology and hepatology, 2010-10, Vol.8 (10), p.877-883

2010

Volltextzugriff (PDF)

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Oncology reports, 2006-07, Vol.16 (1), p.133-140

2006

Volltextzugriff (PDF)

Diagnosis and Management of Patients With α1 -Antitrypsin (A1AT) Deficiency

Clinical gastroenterology and hepatology, 2012-06, Vol.10 (6), p.575-580

2012

Volltextzugriff (PDF)

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

The American journal of gastroenterology, 2019-11, Vol.114 (11), p.1753-1763

2019

Volltextzugriff (PDF)

Clinical presentation and natural course of hepatocellular carcinoma

European journal of gastroenterology & hepatology, 2005-05, Vol.17 (5), p.485-489

2005

Volltextzugriff (PDF)

Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype

Clinical gastroenterology and hepatology, 2015, Vol.13 (1), p.183-192

2015

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Aktive Filter

KollektionIEEE Xplore Digital Library

Zeitschrift / SerieGastroenterology

ThemaInfectious Diseases

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(107)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

Editorial: Feeling better about NASH

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Prevention of Hepatocellular Carcinoma Resulting From Hepatitis B: Are We There Yet?

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Diagnosis and Management of Patients With α1 -Antitrypsin (A1AT) Deficiency

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

Clinical presentation and natural course of hepatocellular carcinoma

Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype

Aktive Filter

Suchergebnisse filtern